Domzalski David
Insider CIK 1727794 · MNLO President and CEO, Director · FOMX CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2026-07-23 | 2026-07-24 | 79,391 | $0.90 | $71.5K | 347,174 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2026-06-30 | 2026-07-02 | 12,214 | $0.65 | $7.9K | 426,565 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2026-05-29 | 2026-06-02 | 30,791 | $0.31 | $9.5K | 438,779 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2026-03-31 | 2026-04-02 | 14,232 | $0.60 | $8.5K | 401,976 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2025-12-31 | 2026-01-05 | 12,684 | $0.58 | $7.4K | 416,208 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2025-09-30 | 2025-10-02 | 12,676 | $0.34 | $4.3K | 428,892 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2025-06-30 | 2025-07-02 | 12,676 | $1.65 | $20.9K | 441,568 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2025-06-02 | 2025-06-03 | 8,681 | $0.81 | $7.0K | 454,244 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2025-03-31 | 2025-04-02 | 30,498 | $1.58 | $48.2K | 445,563 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2025-01-21 | 2025-01-23 | 730,000 | — | $0 | 730,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-12-31 | 2025-01-02 | 24,536 | $3.35 | $82.2K | 476,061 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2024-11-30 | 2024-12-03 | 3,901 | $2.10 | $8.2K | 500,597 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-09-30 | 2024-10-02 | 685 | $1.88 | $1.3K | 496,696 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-07-01 | 2024-07-03 | 935 | $1.92 | $1.8K | 497,654 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2024-05-31 | 2024-06-04 | 4,429 | $2.16 | $9.6K | 498,589 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-04-01 | 2024-04-03 | 1,004 | $3.08 | $3.1K | 494,160 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2024-01-02 | 2024-01-03 | 1,004 | $2.28 | $2.3K | 495,164 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2024-01-01 | 2024-01-03 | 225,000 | — | $0 | 225,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2024-01-01 | 2024-01-03 | 225,000 | — | $0 | 496,168 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2023-12-13 | 2023-12-15 | 225,000 | — | $0 | 225,000 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2023-12-13 | 2023-12-15 | 225,000 | — | $0 | 271,168 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2023-11-30 | 2023-12-04 | 2,284 | $2.81 | $6.4K | 46,168 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2023-10-02 | 2023-10-04 | 8,549 | $3.83 | $32.7K | 43,884 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2023-06-30 | 2023-07-05 | 981 | $4.10 | $4.0K | 52,433 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2023-05-31 | 2023-06-02 | 2,766 | $3.46 | $9.6K | 53,414 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2023-03-31 | 2023-04-04 | 2,734 | $3.08 | $8.4K | 50,648 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2022-12-31 | 2023-01-04 | 10,685 | $0.15 | $1.6K | 1,064,290 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2022-11-30 | 2022-12-02 | 34,705 | $0.20 | $6.9K | 1,074,975 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2022-09-30 | 2022-10-04 | 10,683 | $0.22 | $2.4K | 1,040,270 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2022-06-30 | 2022-07-05 | 10,683 | $0.39 | $4.2K | 1,050,953 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2022-05-31 | 2022-06-02 | 11,887 | $0.35 | $4.2K | 1,061,636 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2022-03-31 | 2022-04-04 | 23,186 | $0.65 | $15.1K | 1,049,749 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2022-03-17 | 2022-03-18 | 312,303 | — | $0 | 312,303 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2022-03-17 | 2022-03-18 | 312,302 | — | $0 | 1,072,935 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2021-12-31 | 2022-01-04 | 6,887 | $1.02 | $7.0K | 760,633 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2021-11-30 | 2021-12-02 | 4,705 | $0.88 | $4.1K | 767,520 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2021-09-30 | 2021-10-01 | 13,096 | $1.39 | $18.2K | 762,815 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2021-09-02 | 2021-09-03 | 320,313 | — | $0 | 320,313 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2021-09-02 | 2021-09-03 | 320,312 | — | $0 | 775,911 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2021-06-30 | 2021-07-02 | 18,859 | $3.51 | $66.2K | 455,599 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2021-05-28 | 2021-06-02 | 941 | $3.36 | $3.2K | 474,458 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2021-03-31 | 2021-04-02 | 6,316 | $6.84 | $43.2K | 473,517 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award deriv | 2021-02-22 | 2021-02-24 | 358,750 | — | $0 | 358,750 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2021-02-22 | 2021-02-24 | 153,750 | — | $0 | 479,833 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2020-12-31 | 2021-01-05 | 9,656 | $1.58 | $15.3K | 1,304,334 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | A Award | 2020-11-30 | 2020-12-02 | 4,263 | $1.45 | $6.2K | 1,313,990 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | F Tax w/h | 2020-09-30 | 2020-10-02 | 6,239 | $1.66 | $10.4K | 1,309,727 | SEC↗ |
| VYNE VYNE Therapeutics Inc. | P Buy | 2020-09-08 | 2020-09-08 | 75,000 | $1.38 | $103.5K | 1,315,966 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | F Tax w/h | 2020-06-30 | 2020-07-02 | 6,239 | $1.73 | $10.8K | 1,240,966 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-05-06 | 2020-05-08 | 680,000 | — | $0 | 680,000 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-05-06 | 2020-05-08 | 680,000 | — | $0 | 1,247,213 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | F Tax w/h | 2020-04-06 | 2020-04-07 | 11,772 | $1.40 | $16.5K | 567,213 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-04-03 | 2020-04-07 | 141,901 | — | $0 | 329,397 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-04-03 | 2020-04-07 | 249,588 | — | $0 | 578,985 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | F Tax w/h | 2020-03-31 | 2020-04-02 | 4,456 | $2.68 | $11.9K | 187,496 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 18,750 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 236,810 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 70,187 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 170,993 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 240,912 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 71,369 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 327,720 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer deriv | 2020-03-09 | 2020-03-11 | 60,000 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 42,278 | — | $0 | 42,278 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 41,578 | — | $0 | 41,578 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 11,107 | — | $0 | 11,107 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 140,286 | — | $0 | 140,286 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 194,141 | — | $0 | 194,141 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 35,544 | — | $0 | 35,544 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 101,296 | — | $0 | 101,296 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2020-03-09 | 2020-03-11 | 142,716 | — | $0 | 142,716 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer | 2020-03-09 | 2020-03-11 | 90,902 | — | $0 | 233,126 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | D To issuer | 2020-03-09 | 2020-03-11 | 233,126 | — | $0 | 0 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-03-09 | 2020-03-11 | 138,102 | — | $0 | 191,952 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award | 2020-03-09 | 2020-03-11 | 53,850 | — | $0 | 53,850 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2020-03-02 | 2020-03-03 | 4,705 | $2.68 | $12.6K | 324,028 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2020-02-24 | 2020-02-24 | 240,912 | — | $0 | 240,912 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2020-02-24 | 2020-02-24 | 103,248 | — | $0 | 319,323 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | F Tax w/h | 2019-12-31 | 2020-01-03 | 2,751 | $3.28 | $9.0K | 216,075 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2019-11-29 | 2019-12-03 | 9,842 | $2.16 | $21.3K | 218,826 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | F Tax w/h | 2019-09-30 | 2019-10-02 | 2,256 | $3.07 | $6.9K | 208,984 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2019-07-01 | 2019-07-03 | 3,355 | $2.35 | $7.9K | 211,240 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2019-04-01 | 2019-04-03 | 5,096 | $3.75 | $19.1K | 214,595 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2019-01-01 | 2019-01-03 | 170,993 | $3.77 | $644.6K | 170,993 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2019-01-01 | 2019-01-03 | 73,282 | — | $0 | 219,691 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2018-12-03 | 2018-12-06 | 68 | $4.05 | $275 | 146,409 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2018-11-19 | 2018-11-20 | 5,036 | $3.90 | $19.6K | 146,477 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2018-11-08 | 2018-11-13 | 2,062 | $4.58 | $9.4K | 151,513 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2018-10-01 | 2018-10-02 | 601 | $5.81 | $3.5K | 153,575 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2018-09-04 | 2018-09-06 | 67 | $5.67 | $380 | 154,176 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2018-08-08 | 2018-08-09 | 8,238 | $5.68 | $46.8K | 154,243 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2018-07-02 | 2018-07-03 | 602 | $5.10 | $3.1K | 162,481 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2018-06-01 | 2018-06-04 | 67 | $5.26 | $352 | 163,083 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award deriv | 2018-05-08 | 2018-05-10 | 70,187 | — | $0 | 70,187 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | A Award | 2018-05-08 | 2018-05-10 | 23,396 | — | $0 | 163,150 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2018-04-02 | 2018-04-04 | 602 | $5.08 | $3.1K | 139,754 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | S Sale | 2018-03-01 | 2018-03-05 | 66 | $5.95 | $393 | 140,356 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | F Tax w/h | 2018-01-02 | 2018-01-24 | 2,397 | $5.98 | $14.3K | 140,422 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise deriv | 2018-01-01 | 2018-01-24 | 5,948 | — | $0 | 0 | SEC↗ |
| FOMX Foamix Pharmaceuticals Ltd | M Exercise | 2018-01-01 | 2018-01-24 | 5,948 | — | $0 | 142,819 | SEC↗ |